Lincoln Krochmal, MD was recently appointed as Chief Medical Officer of Lithera, Inc. According to the company, this appointment reflects the company's continued growth as it prepares to enter late-stage clinical trials and to commercialize its lead product candidate, LIPO-202 (Salmeterol Xinafoate for Injection).

Dr. Krochmal is a board-certified dermatologist and an authority on the development and commercialization of products for the dermatology and aesthetics markets. During his more than 30 year career, he played a pivotal role in the approval of 15 NDAs/ANDAs for new prescription topical dermatologicals including LacHydrin, Ultravate, Dovonex, Evoclin, Verdeso, Olux-E, Extina, and multiple consumer OTC products while with Unilever. Prior to Lithera, Dr. Krochmal was President and Chief Executive Officer of Excaliard Pharmaceuticals, an aesthetics company acquired by Pfizer, Inc., which developed novel treatments for the reduction of skin scarring.

“If successfully developed, LIPO-202 would be the first and only injectable drug treatment for the targeted, non-ablative reduction of subcutaneous abdominal fat,” said Dr. Krochmal in a statement. “These differentiating characteristics would translate into greater convenience, no recovery time, ease of administration and safety, all of which will have clear appeal to the physician and patient and offer a clinically meaningful alternative to liposuction. I look forward to building on the robust clinical profile that Lithera has established for LIPO-202.

Prior to Excaliard Pharmaceuticals, Dr. Krochmal held various senior development and clinical research positions with Connetics Corporation, Westwood Pharmaceuticals, the dermatology subsidiary of Bristol-Myers Squibb, and Unilever PLC. Dr. Krochmal began his career in the pharmaceutical industry following eight years of private dermatology practice. He is a member of the Board of Directors of the International Academy of Cosmetic Dermatology. Additionally, Dr. Krochmal is a fellow of the American Academy of Dermatology, a Diplomat of the American Board of Dermatology and a member of the International Society of Dermatology and the Dermatology Foundation.